Literature DB >> 24583003

High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.

Yvonne Genzel1, Thomas Vogel2, Johannes Buck2, Ilona Behrendt3, Daniel Vazquez Ramirez3, Gudrun Schiedner4, Ingo Jordan5, Udo Reichl6.   

Abstract

High cell densities in animal cell culture can be obtained by continuous perfusion of fresh culture medium across hollow fiber membranes that retain the cells. Careful selection of the membrane type and cut-off allows to control accumulation of target molecules and removal of low molecular weight compounds. In this report, perfusion with the scalable ATF (alternating tangential filtration, Refine Technology) system was evaluated for two suspension cell lines, the avian cell line AGE1.CR and the human cell line CAP. Both were cultivated in chemically defined media optimized for batch cell growth in a 1L stirred tank bioreactor connected to the smallest ATF unit (ATF2) and infected with cell line-adapted human influenza A virus (A/PR/8/34 (H1N1), typical diameter: 80-100 nm). At concentrations of about 25 million cells/mL three different membrane cut-offs (50 kDa, 0.2 μm and 0.5 μm) were tested and compared to batch cultivations performed at 5 million cells/mL. For medium and large cut-offs no cell-density effect could be observed with cell-specific virus yields of 1428-1708 virions/AGE1.CR cell (infected with moi 0.001) and 1883-4086 virions/CAP cell (moi of 0.025) compared to 1292 virions/AGE1.CR cell and 3883 virions/CAP cell in batch cultures. Even at a concentration of 48 million AGE1.CR cells/mL (cut-off: 0.2 μm) a cell-specific yield of 1266 virions/cell was reached. Only for the small cut-off (50 kDa) used with AGE1.CR cells a decrease in cell-specific yield was measured with 518 virions/cell. Surprisingly, the ratio of infectious to total virions seemed to be increased in ATF compared to batch cultures. AGE1.CR cell-derived virus particles were present in the permeate (0.2 and 0.5 μm cut-off), whereas CAP cell-derived virions were not, suggesting possible differences in morphology, aggregation or membrane properties of the virions released by the two cell lines. To our knowledge, this is the first study that illustrates the potential of ATF-based perfusion of chemically defined media across cell-retaining membranes for production of an influenza A vaccine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Batch versus perfusion culture; Cell-density effect; Cell-specific virus yield; Influenza; Membrane cut-off; Suspension cells

Mesh:

Substances:

Year:  2014        PMID: 24583003     DOI: 10.1016/j.vaccine.2014.02.016

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Overcoming nutrient limitations for cell-based production of influenza vaccine.

Authors:  Xu-Ping Liu; Ding Huang; Wen-Song Tan; Jian Luo; Ze Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.

Authors:  Khaled Trabelsi; Meriem Ben Zakour; Ingo Jordan; Volker Sandig; Samia Rourou; Hela Kallel
Journal:  BMC Biotechnol       Date:  2022-06-17       Impact factor: 3.329

Review 4.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

5.  Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode.

Authors:  Juliana Coronel; Gwendal Gränicher; Volker Sandig; Thomas Noll; Yvonne Genzel; Udo Reichl
Journal:  Front Bioeng Biotechnol       Date:  2020-07-02

6.  Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production.

Authors:  Alexander Nikolay; Arnaud Léon; Klaus Schwamborn; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2018-08-08       Impact factor: 4.813

7.  Evaluation of novel disposable bioreactors on pandemic influenza virus production.

Authors:  Chia-Chun Lai; Tsai-Chuan Weng; Yu-Fen Tseng; Jen-Ron Chiang; Min-Shi Lee; Alan Yung-Chih Hu
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

8.  Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs.

Authors:  Sang-Hyun Park; Seo-Yong Lee; Jae-Seok Kim; Ah-Young Kim; Sun-Young Park; Ji-Hye Lee; Mijung Lee; Hyejin Kim; Sim-In Lee; Na-Young Kang; Jung-Won Park; Su-Mi Kim; Jong-Hyeon Park; Young-Joon Ko
Journal:  Vaccines (Basel)       Date:  2021-06-02

9.  Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Authors:  Ding Huang; Wen-Juan Peng; Qian Ye; Xu-Ping Liu; Liang Zhao; Li Fan; Kang Xia-Hou; Han-Jing Jia; Jian Luo; Lin-Ting Zhou; Bei-Bei Li; Shi-Lei Wang; Wen-Ting Xu; Ze Chen; Wen-Song Tan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

10.  Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.

Authors:  Natascha Krömmelbein; Lüder Wiebusch; Gudrun Schiedner; Nicole Büscher; Caroline Sauer; Luise Florin; Elisabeth Sehn; Uwe Wolfrum; Bodo Plachter
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.